Investors are running for the hills because of the coronavirus -- but one of just a handful of S&P 500 stocks that was trading higher Wednesday is up because of hopes that it can treat the virus.
Biotech Gilead Sciences (GILD), which is testing its remdesivir drug in human patients, was up more than 1%. The World Health Organization has previously said that the antiviral vaccine might be the best hope to contain COVID-19.
Insurance brokers Wills Towers Watson (WLTW) and Aon (AON), cloud software firm Citrix (CTXS), web content management firm Akamai (AKAM) and wireless giant T-Mobile (TMUS) were the only other S&P 500 stocks higher in late afternoon trading.